SUBSCRIBE
SUBSCRIBE

Alliances

Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Business
Celgene Revamps Pact With Bay Area Biotech, No Acquisition Coming
August 10, 2017
 · 
3 min read
Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston
Business
Takeda Teams Up With Marvel Comics on Inflammatory Bowel Disease Graphic Novel
August 10, 2017
 · 
4 min read
San Diego's Halozyme Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb and Roche
Business
Bristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III
July 31, 2017
 · 
3 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
LabCorp Scoops Up Giant CRO for Approximately $1.2 Billion Cash
July 31, 2017
 · 
3 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25%
July 28, 2017
 · 
3 min read
Sources Reveal Tesaro is Unlikely to Find a Buyer
Business
Not-Yet Sold Tesaro Bags $340 Million Cancer Deal With Pharma Giant Takeda
July 27, 2017
 · 
2 min read
220 Employees Chopped as Astellas Winds Down SoCal's Agensys
Business
220 Employees Chopped as Astellas Winds Down SoCal’s Agensys, Inc.
July 27, 2017
 · 
3 min read
Alexion is Under Investigation by the HHS Office of Inspector General
Business
Alexion Redefines R&D Strategy, Discontinues Programs and Kills Deals With Moderna, Blueprint and Arbutus Biopharma
July 27, 2017
 · 
3 min read
AstraZeneca PLC Offloads Remaining Anesthetics Portfolio in $766 Million Deal
Business
AstraZeneca PLC Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co.
July 27, 2017
 · 
3 min read
Bay Area's Nektar Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly
Business
Bay Area’s Nektar Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly
July 24, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
August 28, 2025
 · 
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
 · 
4 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Press Releases
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana
July 30, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
 · 
8 min read
Press Releases
Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection
June 27, 2025
 · 
5 min read
Press Releases
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
June 27, 2025
 · 
2 min read
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
 · 
3 min read
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
 · 
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
 · 
10 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
 · 
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
 · 
4 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
 · 
7 min read
Press Releases
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
June 25, 2025
 · 
5 min read
Press Releases
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
June 25, 2025
 · 
5 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
 · 
5 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
 · 
6 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
 · 
5 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
 · 
3 min read
Load More